Your session is about to expire
← Back to Search
Live Donor Champion Program for Liver Disease (LLDC Trial)
N/A
Waitlist Available
Led By Elizabeth A King, MD PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Mentally capable of providing informed consent
Active candidate on the liver transplant waitlist
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 6 months of enrollment
Awards & highlights
LLDC Trial Summary
This trial will enroll liver transplant candidates and their chosen "Live Donor Champion" to see if an abridged education and advocacy training program can expand access to live donor liver transplantation.
Who is the study for?
This trial is for adults over 18 who speak English, are mentally able to consent, and are on the liver transplant waitlist without any current living donors. It's not for those under 18, non-English speakers, anyone with potential live donors already identified, or patients who have had a previous liver transplant or need multiple organs.Check my eligibility
What is being tested?
The study tests an educational and advocacy program called the Liver Live Donor Champion Program. This pilot will evaluate two versions of the program to see how well they help expand access to live donor liver transplants by training 'Live Donor Champions' alongside transplant candidates.See study design
What are the potential side effects?
Since this is an educational and advocacy training program rather than a medical treatment, there are no direct physical side effects associated with participating in this clinical trial.
LLDC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am mentally capable of understanding and agreeing to the trial's procedures.
Select...
I am on the waiting list for a liver transplant.
Select...
I am 18 years old or older.
LLDC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 6 months of enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 6 months of enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Live Donor Inquiries
Live Donor Liver Transplantation
Secondary outcome measures
Comfort initiating conversations
Feasibility - Implementation Outcome
Knowledge of live donation and liver transplantation
LLDC Trial Design
1Treatment groups
Experimental Treatment
Group I: Liver Live Donor ChampionExperimental Treatment1 Intervention
The Liver Live Donor Champion program (LLDC) is the sole educational intervention for this trial. LLDC consists of 2 or 3 monthly sessions (depending on cohort) of approximately 2 or 3 hours each. Each LLDC session is led by a transplant physician or clinical coordinator. The sessions incorporate formal didactics, active-participant learning, personal stories, moderated group discussions, role-playing, and other skill-building exercises. LLDC session topics are as follows: 1) education about End-Stage Liver Disease (ESLD), liver transplantation, and living donation 2) communication skills building 3) Exploring social networks 4) sharing successful donor and recipient stories 5) surgeon and hepatologist panel 6) Program Recap.
Find a Location
Who is running the clinical trial?
Johns Hopkins UniversityLead Sponsor
2,257 Previous Clinical Trials
14,820,055 Total Patients Enrolled
Elizabeth A King, MD PhDPrincipal InvestigatorJohns Hopkins University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had a liver transplant.I am on the waiting list for multiple organ transplants.I am on the waiting list for a liver transplant.I am mentally capable of understanding and agreeing to the trial's procedures.I am under 18 years old.I do not speak English.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Liver Live Donor Champion
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment for this trial still ongoing?
"According to clinicaltrials.gov, this trial has ceased recruiting participants as of August 17th 2022 and was initially posted on September 18th 2018. Although no longer searching for patients, there are 273 other medical studies actively looking for volunteers right now."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger